← Back
$AQST All transactions

Aquestive Therapeutics, Inc.

A

$ Value

$0

Shares

67,500

Price

$0

Filed

Apr 13

Insider

Name

Korczynski Sherry

Title

Chief Commercial Officer

CIK

0002026090

Roles

Officer

Transaction Details

Transaction Date

2025-03-07

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

67,500

Footnotes

This Form 4 was filed late due to an inadvertent administrative oversight. | Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period).

Filing Info

Accession No.

0001214659-26-004593

Form Type

4

Issuer CIK

0001398733

Korczynski Sherry's History

Date Ticker Type Value
2026-03-10 AQST $66K
2026-03-09 AQST A $0
2026-03-09 AQST A $182K
2025-08-14 AQST A $0
2025-06-09 AQST F $10K
2025-03-07 AQST A $0

Other Insiders at AQST (90d)

Insider Bought Sold Last
TOTH A ERNEST JR
Chief Financial Officer
$243K 2026-03-10
TOTH A ERNEST JR
SVP, Chief Financial Officer
2025-03-07
Boyd Peter E.
Chief People Officer
$124K 2026-03-10
Barber Daniel
President and CEO
$754K 2026-03-10
BRAENDER LORI J
Chief Legal Officer
$167K 2026-03-10
BRAENDER LORI J
Corporate Secretary
2025-03-07
Jung Cassie
Chief Operating Officer
$191K 2026-03-10
Korczynski Sherry
Chief Commercial Officer
$66K 2026-03-10
Cioffi Melina
SVP, Regulatory Affairs
$106K 2026-03-10
Davis Matthew W.
Chief Development Officer
2026-03-09
Greenhawt Matthew J.
Chief Medical Officer
2026-03-09